장티푸스 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Typhoid Fever Vaccine Trends and Forecast

The future of the global typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets. The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030 with a CAGR of 14.5% from 2024 to 2030. The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.

A more than 150-page report is developed to help in your business decisions.

Typhoid Fever Vaccine by Segment

The study includes a forecast for the global typhoid fever vaccine by type, route of administration, end use, and region.

Typhoid Fever Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Live Attenuated Vaccine
• Capsular Polysaccharide Vaccine
• Conjugate Vaccine
• Others

Typhoid Fever Vaccine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Injection

Typhoid Fever Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Specialty Centers
• Others

Typhoid Fever Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Typhoid Fever Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies typhoid fever vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the typhoid fever vaccine companies profiled in this report include-

• EMERGENT
• Bio Farma
• Bharat Biotech
• BIO-MED
• Pfizer
• GlaxoSmithKline
• Novartis
• Mylan
• Teva Pharmaceutical
• Sanofi

Typhoid Fever Vaccine Market Insights

Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.

Within this market, hospital & clinic is expected to witness highest growth over the forecast period.

North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.

Features of the Global Typhoid Fever Vaccine Market

Market Size Estimates: Typhoid fever vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Typhoid fever vaccine market size by type, route of administration, end use, and region in terms of value ($B).

Regional Analysis: Typhoid fever vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, route of administration, end uses, and regions for the typhoid fever vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the typhoid fever vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the typhoid fever vaccine market size?

Answer: The global typhoid fever vaccine market is expected to reach an estimated $1.0 billion by 2030.

Q.2 What is the growth forecast for typhoid fever vaccine market?

Answer: The global typhoid fever vaccine market is expected to grow with a CAGR of 14.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the typhoid fever vaccine market?

Answer: The major drivers for this market are rise in the prevalence of typhoid and growing demand for combined vaccines that offer protection against multiple diseases.

Q4. What are the major segments for typhoid fever vaccine market?

Answer: The future of the typhoid fever vaccine market looks promising with opportunities in the hospital & clinic and specialty center markets.

Q5. Who are the key typhoid fever vaccine market companies?

Answer: Some of the key typhoid fever vaccine companies are as follows:

• EMERGENT
• Bio Farma
• Bharat Biotech
• BIO-MED
• Pfizer
• GlaxoSmithKline
• Novartis
• Mylan
• Teva Pharmaceutical
• Sanofi

Q6. Which typhoid fever vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that capsular polysaccharide is expected to witness highest growth over the forecast period due to its efficiency at preventing infection from the bacteria, safe with limited side effects, and it can be administered orally or by injection, making them easy and convenient to use.

Q7. In typhoid fever vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing demand for vaccines across all age groups and high awareness for the typhoid vaccines in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the typhoid fever vaccine market by type (live attenuated vaccine, capsular polysaccharide vaccine, conjugate vaccine, and others), route of administration (oral and injection), end use (hospitals & clinics, specialty centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Typhoid Fever Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Typhoid Fever Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Typhoid Fever Vaccine Market by Type
  • 3.3.1: Live Attenuated Vaccine
  • 3.3.2: Capsular Polysaccharide Vaccine
  • 3.3.3: Conjugate Vaccine
  • 3.3.4: Others
• 3.4: Global Typhoid Fever Vaccine Market by Route of Administration
  • 3.4.1: Oral
  • 3.4.2: Injection
• 3.5: Global Typhoid Fever Vaccine Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Specialty Centers
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Typhoid Fever Vaccine Market by Region
• 4.2: North American Typhoid Fever Vaccine Market
  • 4.2.2: North American Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
• 4.3: European Typhoid Fever Vaccine Market
  • 4.3.1: European Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
  • 4.3.2: European Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
• 4.4: APAC Typhoid Fever Vaccine Market
  • 4.4.1: APAC Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
  • 4.4.2: APAC Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others
• 4.5: ROW Typhoid Fever Vaccine Market
  • 4.5.1: ROW Typhoid Fever Vaccine Market by Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccine, Conjugate Vaccine, and Others
  • 4.5.2: ROW Typhoid Fever Vaccine Market by End Use: Hospitals & Clinics, Specialty Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Route of Administration
  • 6.1.3: Growth Opportunities for the Global Typhoid Fever Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global Typhoid Fever Vaccine Market by Region
• 6.2: Emerging Trends in the Global Typhoid Fever Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Typhoid Fever Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Typhoid Fever Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: EMERGENT
• 7.2: Bio Farma
• 7.3: Bharat Biotech
• 7.4: BIO-MED
• 7.5: Pfizer
• 7.6: GlaxoSmithKline
• 7.7: Novartis
• 7.8: Mylan
• 7.9: Teva Pharmaceutical
• 7.10: Sanofi